The global kidney transplant market enjoys a valuation of USD 5.8 Billion in 2023, and it is further projected to expand at a CAGR of 2.8% over the forecasted years. According to a recent study by Future Market Insights, deceased-donor kidney transplants are leading the market with a share of about 74.7% in the year 2022, within the global market.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2023 | USD 5.8 Billion |
| Market Value 2033 | USD 9.1 Billion |
| CAGR 2023 to 2033 | 4.2% |
| Market Share of Top 5 Countries | 87.5% |
Kidney transplant is also known as renal transplant. A kidney transplant is a surgical procedure that replaces a damaged kidney with a healthy kidney obtained from a donor. The kidney could come from either a deceased organ donor or a living donor. Recently, paired kidney exchange and domino paired donation (DPD) are also begin implemented by different kidney donation organizations and service providers.
Kidney transplant is primarily concerned with non-invasive monitoring and the advancement of histological diagnosis through the use of molecular methods. Such studies provide novel avenues for discovering immunosuppressive agents capable of effectively overcoming critical sensitization, preventing the formation of anti-HLA antibodies, treating chronic active antibody-mediated rejection (ABMR), and reducing non-immunological complications succeeding kidney transplant, such as the occurrences of primary kidney disease and other complications such as cardiovascular disease, infections, and malignancy.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global organ transplant market is valued at 29.1 Billion in the year 2021 and the kidney transplant market holds a market share of 19.4% owing to factors such as growing end-organ dysfunction and the prevalence of chronic diseases such as cancer and diabetes.
The global sales of the market are anticipated to rise at a CAGR of 4.2% between 2023 and 2033, owing to the rising prevalence of various renal disorders and kidney failure. Chronic kidney disease is a particularly large burden in low- and middle-income nations, which are the least prepared to deal with its repercussions.
One of the key factors propelling the growth of the market in the coming years is the surge in the demand for minimally invasive procedures and also due to the various benefits offered by these surgeries.
Kidney transplant is done by robotic surgery and laparoscopic surgery. Robotic surgery has the advantage where that vascular anastomosis was felt easier to perform as a result of the 3D vision and the 7-degree movement of the instrument, while laparoscopic surgery is limited in the finer movement of the instrument. In the future, innovation is still necessary to discover a better approach and therefore to facilitate vessel anastomosis. In addition, the extraperitoneal approach will be more beneficial, as this would avoid violating the intraperitoneal cavity and organs.
In this day and age of EHRs, it is widely assumed artificial intelligence and big data will transform kidney transplant research in the near future. Furthermore, the use of telemedicine is growing, with advantages such as connecting to kidney transplant patients in rural places and assisting in making scarce healthcare resources more available for kidney transplants.
Owing to the above-mentioned factors, the global market is expected to grow at a prominent pace, and reach a valuation of around USD 9.1 billion in the year 2033.
The market is anticipated to expand due to the ongoing demand for kidney transplants, creating a huge opportunity for the organizations and facilities associated with transplant procedures to step in and innovate unique ways to achieve efficiency and cost-effectiveness.
Costs continue to increase related to kidney transplants for patients with end-stage kidney disease (ESKD), which is reflected in the concerted efforts to expand the kidney transplant waiting list in recent years. In recent years, there has been a push to improve access to kidney transplants for patients with end-stage kidney disease. Transplant hospitals have also seen an increase in kidney waiting list volumes, kidney waiting list active volumes, kidney transplant volumes, and the comorbidity burden.
The existence of a waiting list demonstrates that a scarcity of kidneys, rather than a shortage of individuals qualified for transplants, is restricting the number of kidney transplants in the United States.
More than 106,000 patients are on the national transplant waiting list, comprising 92,000 (87%) awaiting a kidney transplant.
Hence, the rise in the number of patients on the waitlist is likely to act as an opportunity in the kidney transplant market.
Principal Consultant
The market is expected to grow owing to the rising number of procedures and FDA approvals. However, some factors limit the market.
One of the significant barriers to the kidney transplant industry is the high cost associated with the procedure. The cost of the procedure is a critical issue in determining whether it can be performed. The costs for such procedures are fairly high, this is regarded as a constraining issue for this market.
The cost of a kidney transplant includes multiple factors such as the cost of the procedure, hospitalization, post-transplant therapy, etc.
For instance, the immunosuppression required by a transplant recipient costs £5,000 per patient per year.
A single kidney transplant costs can cost around USD 260,000, whereas a combination heart and lung transplant costs more than USD 1.2 million dollars. Long-term oral immunosuppression and other prescription medications, on the other hand, can cost patients up to USD 2,500 per month depending on a variety of factors such as the number of prescription medications. This is expensive for most of the population and most of them are unable to access it.
Such a high cost of the procedure makes it difficult to access and patients tend to rely on dialysis. Hence, the cost of the procedure is restricting the kidney transplant market.
The USA dominates the North American region with a total market share of around 98.7% in 2022 and is expected to continue to experience the same growth throughout the forecast period.
As per the data from the United States Renal Data System, in the United States December 2018, there were 229,887 individuals having a functional kidney transplant, or 678 recipients per million persons, marking a 40% increase since 2008. A total of 24,273 kidney transplants were done in the United States in 2019. Almost 72% of these kidney donations came from deceased donors.
Since the number of donors and transplant procedures is increasing in USA surgery, market.
China holds a market share of 79.7% in 2022 in the East Asian kidney transplant market, owing to China’s increase in registered organ donation volunteers, and the government amending organ transplant rules.
According to global times, above 1.77 million people have registered as organ donation volunteers at the China Organ Transportation Development Foundation (COTDF), encouraging voluntary organ donation and equal organ distribution nationwide, in 2021.
The number shows an increase of about 46.5 percent compared with the number at the end of 2019, despite the impact of the epidemic.
India holds a share of around 62.2% in the South Asia market in 2022. India is working to raise public awareness about organ transplants. Under the direction of the National Organ and Tissue Transplant Organization (NOTTO), the rate of kidney transplants has been gradually growing (from 3.22 million people in 2013 to 5.86 million people in 2018). In addition, five additional regional centers have been built to manage organ procurement and distribution activities. The facilities are active in data registration maintenance, networking, and organ donation advocacy with an emphasis on promoting awareness. The Transplant of Human Organs Act was developed in 1994 to prohibit organ trade, and it was updated in 2011 by Parliament to include punishments such as jail time and fines for violators.
Brazil has a market share of 22.1%, with a market value of USD 39.9 Million in the Latin America kidney transplant market in 2022.
To meet the requirements of patients, kidney-paired donation (KPD) schemes of various dimensions, acceptance standards, and distribution criteria are being established and extended globally. The increased transplantability caused by KPD mostly addresses the demands of severely sensitized patients. The Brazilian transplant program is sufficiently advanced to take on the task of launching its KPD program, which is primarily meant to help patients who have a poor chance of obtaining a transplant from a deceased donor.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Deceased-donor kidney transplants are expected to give high growth at a CAGR of 4.5% between 2023 and 2033. Kidneys from a deceased donor are typically obtained with a large quantity of surrounding tissue, including the perineal fat, adrenal gland, and parts of the aorta and inferior vena cava (IVC). As a result, the first stage in the deceased-donor kidney transplant operation is to appropriately prepare the graft for transplant. These considerations encourage the use of deceased-donor kidney transplants across the world. End-stage renal disease (ESRD) and kidney failure.
Kidney transplant procedures are mostly performed in adults. It has a market share of 91.9% in the global market in 2022.
The aging of the ESRD population is increasing the need for kidney transplants among older persons. In the kidney transplant waiting list, there is a considerable and growing number of elderly patients, both active and inactive. Over the last decade, the number of newly transplanted patients over the age of 65 has more than doubled and is anticipated to rise further. The growing life expectancy and older population globally, thus promote kidney transplant market expansion.
Hospitals hold a market share of 54.8% during the year 2022. Hospitals are the principal facilities where patients assemble, and where essential and technologically sophisticated surgical operations are performed. Transplant surgeons often perform the surgery in a hospital setting. Hospitals are centres of excellence, and these are high-end surgeries that have a low volume but a high cost. Because of the comprehensive treatment provided in hospital settings, the category is expected to grow at a profitable pace throughout the projection period.
Increasing the treatment efficacy process during pre and post-kidney transplant, collaborations and partnerships among foundations located in different geographic locations, and running awareness programs are key differentiating strategies that are adopted by transplant service providers. The market's dynamics have changed due to increased awareness.
Instances of important developmental strategies used among market participants in the kidney transplant market are presented below
Similarly, recent developments related to companies providing services and foundations related to kidney transplants have been tracked by the team at Future Market Insights. These are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2017 to 2022 |
| Historical Data Available for | 2023 to 2033 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and the Middle East & Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Argentina, The United Kingdom, Germany, Italy, Russia, Spain, France, Benelux, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, North Africa, and South Africa |
| Key Market Segments Covered | Transplant, Age Group, End User, and Region |
| Pricing | Available upon Request |
The market is estimated to reach USD 9.1 billion by 2033.
The growth potential of the kidney transplant market is 4.2% CAGR through 2033.
The primary deployer for kidney transplant is hospitals.
Surging demand for minimally invasive procedures is expected to drive the market forward.
Ongoing demand for kidney transplants is expected to create opportunity for market players.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value-Added Insights 5. Market Background 6. COVID-19 Crisis Analysis 7. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Transplant Type 8.1. Deceased-Donor Kidney Transplant 8.2. Living-Donor Kidney Transplant 8.2.1. Direct Donation Kidney Transplant 8.2.2. Non-directed Donation Kidney Transplant 8.2.3. Paired Exchange Kidney Transplant 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Age Group 9.1. Adults 9.2. Pediatrics 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 10.1. Hospitals 10.2. Transplant Centers 10.3. Academic and Research Institutes 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region 11.1. North America 11.2. Latin America 11.3. Europe 11.4. Middle East and Africa (MEA) 11.5. South Asia 11.6. East Asia 11.7. Oceania 12. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 13. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18. Middle East and Africa (MEA) Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19. Assumptions and Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Kidney Transplant Market
